午夜视频在线播放,久久久无码精品亚洲A片消消乐

国产一级婬片A片免费无成人黑豆,亚洲AV无码乱码精品,黄色网址免费在线观看,少妇高潮久久久久久潘金莲

<noscript id="ccccc"><optgroup id="ccccc"></optgroup></noscript>

CN

CN EN

Latest News

Latest News Media Downloads Video Center

Kexing Biopharm's clinical trial application accepted for human interferon α1b inhalation solution
2022-08-19

2022-08-19

On the evening of August 18, 2022, Kexing Biopharm...
Kexing Biopharm's clinical trial application accepted for another dosage form of human interferon α2b
2022-08-15

2022-08-15

On the evening of August 14, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had recently received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Human Interferon α2b Spray" was accepted.
Kexing Biopharm's clinical trial application accepted for "Pegylated Human Granulocyte Colony-stimulating Factor Injection"
2022-08-02

2022-08-02

On the evening of August 1, 2022, Kexing Biopharm Co., Ltd. (hereinafter referred to as "the Company" or "Kexing Biopharm") announced that it had just received the Notice of Acceptance, an administrative license document issued by the National Medical Products Administration (hereinafter referred to as "NMPA"), indicating that its clinical trial application for "Pegylated Human Granulocyte Colony-stimulating Factor Injection" was accepted.
Kexing Biopharm's conference for reviewing operation and management in first half of 2022and planning key tasks for the second half-year held successfully
2022-08-01

2022-08-01

In the face of the complicated political and economic environment in China and overseas as well as the tough situation in the pharmaceutical industry, Kexing Biopharm proposed the working policy themed as "intensely licensing in new products, firmly promoting R&D and innovation, and proactively creating business in new industries" at the beginning of the year, and continuously followed and implemented the policy in the first half-year.
Phase I clinical trial kick-off meeting of Kexing Biopharm's COVID-19 oral drug SHEN26 Capsule held successfully
2022-07-22

2022-07-22

On July 20, 2022, the phase I clinical trial kick-off meeting of SHEN26 Capsule, a small-molecule oral drug against COVID-19 jointly developed by Shenzhen Kexing Pharmaceutical Co., Ltd., a wholly-owned subsidiary of Kexing Biopharm (688136.SH), and Shenzhen Antiv Pharma Co., Ltd., was successfully held in the Second Affiliated Hospital of Anhui Medical University, indicating the official start of the clinical study for the project.

1 2 3 4 5

Support Hotline

0755-26546500
Online Consultation
QR Code

Scan Code Consultation

国产小视频在线不卡 | 性做爰A片欧美激情艳妇20p | 国产中文字幕在线观看 | 丰满人妻老熟妇伦人精品 | 日本有码一区二区三区 | 午夜丰满极品美女A片 | 美国A级毛片免费视频 | 人人妻人人澡人人精品 | 精品成人无码久久久久久 | 99久久久国产精品免费蜜臀 | 国产午夜精品一区二区三区牛牛 | 蜜桃av色偷偷av老熟女 | 海角社区91在线熟女写真 | 中文字幕永久精品国产 | 丰满的双乳一级A片视频 | 成人爱爱视频免费在线播放 | 国产又粗又大又爽视频 | 91AV网站在线观看 | 少妇无码Av毛片区爆乳一区二区 | 无码人妻欧美一区二区三区 | 国产xxx视频免费看亚洲乱码日产精品BD | 无码八A片人妻少妇久久 | 亚洲熟伦熟女新五十路熟妇 | 91无码精品国产 | 国产高清无码一区二区三区 | 亚洲jizz无码人妻 | 成人无码区免费A片视频野外 | 女女蕾丝边一区二区三区国产 | 国产亚洲精品无码久久久 | 中文字幕一区二区三区乱码 | 农村婬乱男女A片爽视频麻豆软件 | 特级西西人体444w w w | 91精品久久久久久久 | 日韩无码一级片播放器 | 午夜视频在线观看国产 | 亚洲女子裸体在线观看 | 专干老熟女300部 | 亚洲欧美日韩丝袜自慰 | 黄色视频无码在线观看 | 91在线无码秘入口在线 | 91在线无码精品秘入口竹美 |

<nav id="c0cc0"><code id="c0cc0"></code></nav>

<noscript id="c0cc0"></noscript>